Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
192.54
+6.18 (3.32%)
At close: May 18, 2026, 4:00 PM EDT
194.99
+2.45 (1.27%)
Pre-market: May 19, 2026, 6:29 AM EDT
Natera Employees
Natera had 6,140 employees as of December 31, 2025. The number of employees increased by 1,706 or 38.48% compared to the previous year.
Employees
6,140
Change (1Y)
1,706
Growth (1Y)
38.48%
Revenue / Employee
$407,317
Profits / Employee
-$36,859
Market Cap
27.57B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6,140 | 1,706 | 38.48% |
| Dec 31, 2024 | 4,434 | 1,141 | 34.65% |
| Dec 31, 2023 | 3,293 | 275 | 9.11% |
| Dec 31, 2022 | 3,018 | 348 | 13.03% |
| Dec 31, 2021 | 2,670 | 855 | 47.11% |
| Dec 31, 2020 | 1,815 | 776 | 74.69% |
| Dec 31, 2019 | 1,039 | 64 | 6.56% |
| Dec 31, 2018 | 975 | 82 | 9.18% |
| Dec 31, 2017 | 893 | 41 | 4.81% |
| Dec 31, 2016 | 852 | 136 | 18.99% |
| Dec 31, 2015 | 716 | 42 | 6.23% |
| Dec 31, 2014 | 674 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 93,000 |
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| Agilent Technologies | 18,100 |
| Mettler-Toledo International | 18,100 |
| IDEXX Laboratories | 11,000 |
| Revvity | 11,000 |
| Illumina | 10,080 |
NTRA News
- 3 days ago - Signatera CDx approved by FDA as companion diagnostic in MIBC - TheFly
- 3 days ago - Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC) - Business Wire
- 5 days ago - The Cancer Test That Wall Street Is Betting On - WSJ
- 5 days ago - Cathie Wood’s ARK Investment buys 17.3K shares of Natera today - TheFly
- 6 days ago - Natera price target raised to $249 from $240 at Piper Sandler - TheFly
- 10 days ago - Natera price target raised to $270 from $250 at Evercore ISI - TheFly
- 10 days ago - Natera price target raised to $265 from $257 at Baird - TheFly
- 10 days ago - Natera price target raised to $265 from $260 at JPMorgan - TheFly